• Economy
  • Editor’s Pick
Money Rise Today – Investing and Stock News
  • Investing
  • Stock
Investing

Moderna stock fires past 52-week high: what’s behind Friday’s rally?

by October 9, 2026
written by October 9, 2026

Moderna MRNA shares jumped more than 9% in early trading Friday, reaching a fresh 52-week high as the biotechnology company returned to the Nasdaq-100 index.

Moderna hit a 52-week high of $216.95. It lost some of the gains and was trading at $208.69, up 5.9% at the time of writing.

The broader market was also higher, with all three major US stock indexes gaining as Treasury yields cooled and oil prices declined.

Nasdaq-100 inclusion adds fuel

Moderna’s return to the Nasdaq-100 is proving to be the major catalyst for the stock.

The company had previously been part of the index before being removed following a decline in its shares after the pandemic. Its shares had fallen to as low as $22 before scripting a dramatic comeback.

Its re-entry comes after a sharp recovery in its market performance, with a rise of over 670% in one year. It has been among the most outstanding performers in the market this year.

The biotechnology company is replacing Warner Bros. Discovery in the technology-heavy index.

The inclusion has created additional demand for Moderna shares as index funds and exchange-traded funds that track the Nasdaq-100 adjust their portfolios to reflect the change.

The index is tracked by more than 200 investment products with over $800 billion in assets, broadening the pool of investors exposed to Moderna, who now have to include the biotech company in their funds.

Cancer therapy pipeline remains key

Investors are also looking ahead to Moderna’s oncology pipeline, particularly the upcoming Phase 3 data for intismeran autogene, an individualized neoantigen therapy developed in collaboration with Merck.

The data are scheduled to be presented on October 24. The positive Phase 3 results have been described as a historic milestone for commercialized individualized mRNA cancer therapy, attracting attention from investors and Wall Street.

Moderna has also announced Juan Andres as its new chief operating officer as the company looks toward potential expansion in oncology and a broader portfolio of commercial vaccines.

These developments are adding to investor interest beyond the immediate impact of the Nasdaq-100 inclusion.

Stock price trading above analysts’ target price

However, the stock’s substantial rise also raises questions about how much of the anticipated progress has already been reflected in its valuation.

Investors will be watching whether developments in Moderna’s pipeline can translate into sustained financial gains over the longer term.

Earlier this month, Morgan Stanley raised its price target on Moderna to $95 from $89 while maintaining an Equal-Weight rating.

Citigroup analyst Geoff Meacham, meanwhile, downgraded the stock to Sell from Neutral, although he raised his price target to $80 from $60.

Both price targets remain well below Moderna’s current trading level of just above $200.

These numbers indicate that analysts are still taking a cautious view of the stock even as the bull run refuses to end.

The post Moderna stock fires past 52-week high: what’s behind Friday’s rally? appeared first on Invezz

0 comment
0
FacebookTwitterPinterestEmail

previous post
Nasdaq opens higher as oil retreats, AI stocks recover and telecom shares slide
next post
Oracle stock is wavering: will its revenue growth and bargain status spark a rebound?

related articles

Lenovo Group stock analysis after earnings: is this...

November 19, 2026

Samsung and SK Hynix stocks fall again as...

November 19, 2026

Anthropic IPO prices at $83 a share as...

November 18, 2026

Evening digest: Anthropic IPO demand surges as gold...

November 18, 2026

SpaceX stock rises as Citi sees wireless network...

November 18, 2026

Why is Nvidia stock falling over 2% on...

November 18, 2026

Cathie Wood was right on the money about...

November 18, 2026

When could Anthropic stock join the MSCI, Russell,...

November 18, 2026

Nvidia earnings: investors still need answers to two...

November 18, 2026

Strategy stock falls as analyst warns MSTR could...

November 18, 2026
Enter Your Information Below To Receive Free Trading Ideas, Latest News, And Articles.


Your information is secure and your privacy is protected. By opting in you agree to receive emails from us. Remember that you can opt-out any time, we hate spam too!

Latest News

  • Caterpillar stock drops below key support as Citi, Truist slashes target

    October 13, 2026
  • Is Rolls-Royce share price set to soar after some good news from China?

    June 26, 2026
  • Digital Realty stock drops 4%, but here’s why market may be wrong

    June 30, 2026
  • Key swing state voters to settle dueling Senate primary fights in crucial open-seat race

    September 8, 2026
  • Qualcomm eyes modular AI deal as stock falls on tech selloff pressure

    June 23, 2026

Popular Posts

  • 1

    Why SpaceX stock is down around 3% on Tuesday

    September 15, 2026
  • 2

    Micron stock falls 4%, why this analyst sees 40% upside for the stock?

    September 28, 2026
  • 3

    Evening digest: US jobs cool, gold falls as Treasury yields rise

    October 2, 2026
  • 4

    Nike stock sinks after earnings as its comeback plan turns into more layoffs

    October 2, 2026
  • 5

    Intel, AMD stocks slide again in aftermath of Broadcom’s weak outlook

    June 5, 2026

Categories

  • Editor's Pick (711)
  • Investing (2,630)
  • Stock (90)

Latest Posts

  • easyJet shares jump after airline agrees in principle to Castlelake’s $7.3B takeover

    July 6, 2026
  • Tilray Brands stock has crashed to a record low: is this fallen angel a buy?

    November 17, 2026
  • Analyst: Adobe stock’s post-earnings dip isn’t about AI disruption fears only

    September 11, 2026

Recent Posts

  • Inside the dangerous US mission that cleared Iran’s mines from Hormuz shipping lanes

    August 31, 2026
  • Hong Kong financial stocks tumble as China tightens offshore checks

    June 5, 2026
  • Blue state’s water failures could threaten food supplies across US, lawmaker warns

    August 25, 2026

Editor’s Pick

  • ‘Castro’s playbook’: Ex-AG warns dozens of congressional bills are pushing socialist ideas

    September 25, 2026
  • KNDS IPO: the $23 billion defence bet that could reshape Europe’s armies

    June 24, 2026
  • KOSPI slips despite Samsung’s record quarter while Nikkei falls below 70,000

    October 8, 2026
  • About us
  • Contacts
  • Privacy Policy
  • Terms & Conditions

Disclaimer: moneyrisetoday.com, its managers, its employees, and assigns (collectively “The Company”) do not make any guarantee or warranty about what is advertised above. Information provided by this website is for research purposes only and should not be considered as personalized financial advice. The Company is not affiliated with, nor does it receive compensation from, any specific security. The Company is not registered or licensed by any governing body in any jurisdiction to give investing advice or provide investment recommendation. Any investments recommended here should be taken into consideration only after consulting with your investment advisor and after reviewing the prospectus or financial statements of the company.

Copyright © 2025 moneyrisetoday.com | All Rights Reserved

Money Rise Today – Investing and Stock News
  • Economy
  • Editor’s Pick
Money Rise Today – Investing and Stock News
  • Investing
  • Stock